Kymera Therapeutics (KYMR)
(Delayed Data from NSDQ)
$33.62 USD
-1.04 (-3.00%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $33.59 -0.03 (-0.09%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/2/24 |
---|---|
Current Quarter | -0.73 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | 43.18% |
ABR | 1.75 |
Earnings ESP
|
3.78% |
---|---|
Current Year | -3.15 |
Next Year | -3.44 |
EPS (TTM) | -2.52 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.86M | 11.64M | 55.76M | 70.79M |
# of Estimates | 9 | 9 | 10 | 10 |
High Estimate | 15.40M | 26.90M | 125.00M | 129.10M |
Low Estimate | 6.30M | 0.20M | 15.20M | 35.00M |
Year ago Sales | 9.47M | 16.51M | 78.59M | 55.76M |
Year over Year Growth Est. | 25.18% | -29.47% | -29.05% | 26.96% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.73 | -0.75 | -3.15 | -3.44 |
# of Estimates | 11 | 10 | 13 | 12 |
Most Recent Consensus | -0.57 | -0.41 | -1.89 | -3.56 |
High Estimate | -0.57 | -0.41 | -1.89 | -1.93 |
Low Estimate | -0.87 | -0.89 | -4.16 | -4.56 |
Year ago EPS | -0.70 | -0.67 | -2.52 | -3.15 |
Year over Year Growth Est. | -4.29% | -11.94% | -25.00% | -9.18% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 2 | 1 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.73 | -0.75 | -3.15 | -3.44 |
7 Days Ago | -0.73 | -0.75 | -3.15 | -3.44 |
30 Days Ago | -0.73 | -0.78 | -3.16 | -3.42 |
60 Days Ago | -0.75 | -0.78 | -3.24 | -3.47 |
90 Days Ago | -0.70 | -0.68 | -3.08 | -3.09 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.71 | -0.63 | -2.63 | -3.72 |
Zacks Consensus Estimate | -0.73 | -0.75 | -3.15 | -3.44 |
Earnings ESP | 3.78% | 17.00% | 16.71% | -8.11% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | -0.90 | -0.67 | -0.70 | NA |
Estimate | -0.44 | -0.73 | -0.70 | -0.69 | NA |
Difference | 0.19 | -0.17 | 0.03 | -0.01 | 0.01 |
Surprise | 43.18% | -23.29% | 4.29% | -1.45% | 5.68% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more